Application of extended criteria donor grafts in liver transplantation for acute-on-chronic liver failure: A retrospective cohort study

Table 1 Baseline characteristics of recipients, n (%)

	ECD (n = 78)	Non-ECD (n = 67)	P value
MELD	30.73 ± 5.96	30.19 ± 5.60	0.579
MELD			0.547
> 30	40 (51.3)	31 (46.3)
≤ 30	38 (48.7)	36 (53.7)
OFs			0.591
0	25 (32.1)	28 (41.8)
1	33 (42.3)	20 (29.9)
2	11 (14.1)	9 (13.4)
3	7 (9)	8 (11.9)
4	2 (2.6)	2 (3)
OFs			0.547
> 2	9 (11.5)	10 (14.9)
≤ 2	69 (88.5)	57 (85.1)
Age (yr)			0.365
> 60	4 (5.1)	6 (9)
≤ 60	74 (94.9)	61 (91)
Sex			0.730
Male	69 (88.5)	58 (86.6)
Female	9 (11.5)	9 (13.4)
BMI (kg/m2)			0.611
> 30	5 (6.4)	3 (4.5)
≤ 30	73 (93.6)	64 (95.5)
Blood group			0.411
O	29 (37.2)	28 (41.8)
A	24 (30.8)	20 (29.9)
B	22 (28.2)	13 (19.4)
AB	3 (3.8)	6 (9)
WBC (× 109/L)	6.84 ± 3.56	6.35 ± 3.52	0.411
N/L	6.27 ± 6.34	7.00 ± 6.12	0.482
Hb (g/L)	94.27 ± 22.29	89.45 ± 19.06	0.167
GGT (U/L)	49.51 ± 26.39	50.12 ± 32.49	0.901
ALB (g/L)	36.87 ± 4.94	38.37 ± 4.99	0.071
ALT (U/L)	85.33 ± 96.36	60.88 ± 75.02	0.088
AST (U/L)	114.47 ± 103.80	92.42 ± 82.42	0.163
PLT (× 109/L)	63.50 ± 33.83	62.49 ± 38.57	0.867
Fib (g/L)	1.02 ± 0.47	1.12 ± 0.43	0.176
IFLT	2 (2.6)	5 (7.5)	0.170

MELD: Model for end-stage liver disease; ECD: Extended criteria donor; OFs: Organ failures; BMI: Body mass index; WBC: White blood cell; Hb: Hemoglobin; GGT: Gamma glutamyltransferase; ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PLT: Platelets; Fib: Fibrinogen; IFLT: Ischemia-free liver transplantation.